Author:
Peters PJ,Stringer J,McConnell MS,Kiarie J,Ratanasuwan W,Intalapaporn P,Potter D,Mutsotso W,Zulu I,Borkowf CB,Bolu O,Brooks JT,Weidle PJ
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference47 articles.
1. WHO. http://www.who.int/hiv
2. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine;Van Leth;a randomised open-label trial, the 2NN study,2004
3. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy;Watts;Am J Obstet Gynecol,2004
4. Teratogenicity risk of antiretroviral therapy in pregnancy;Watts;Curr HIV/AIDS Rep,2007
5. Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients;Bonjoch;AIDS Res Hum Retroviruses,2006
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献